Investigating the Clinical Utility of the Oxford Virtual Autism Assessment Tool (OVAAT)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13-18
SponsorOxford Health NHS Foundation Trust
About this trial
The goal of the study is to evaluate a new Autism Spectrum Disorder (ASD) diagnostic tool (Oxford Virtual Autism Assessment Tool (OVAAT)) to see whether it can:
* Be able to identify autistic traits * Be able to distinguish between autistic and non-autistic young people * Is the tool better, similar or worse than another evidence-based observational tool (ADOS-2) in identifying features of autism?
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Group 1: 13-18 year old young people waiting for an autism assessment in the Oxfordshire CAMHS Neurodevelopmental Conditions (NDC) pathway who have access to and are able to use a laptop or desktop computer and a quiet place to complete the assessment.
Group 2: 13-18 year old young people with no neurodevelopmental or mental health conditions who have access to and are able to use a laptop or desktop computer and a quiet place to complete the assessment.
Disqualifiers
Group 1: 13-18 year old young people waiting for an autism assessment in the Oxfordshire CAMHS NDC pathway who have an existing or suspected neurodevelopmental diagnosis other than autism (e.g. ADHD, Learning Disability) or significant mental health problem (e.g. major depression, psychosis, eating disorder) and/or who are unable to speak English fluently.
Group 2: 13-18 year olds with any suspected or current neurodevelopmental or mental health conditions and/or who are unable to speak English fluently.
Trial design
Design model
Crossover
Treatments tested in this trial
Oxford Virtual Autism Assessment Tool (OVAAT)
Diagnostic testThe OVAAT is an online ASD diagnostic tool that has been designed to identify both the external/observable features of autism but also the internal/experiential features of autism.
Treatment groups
60 Participants
are divided into 2 treatment groupsGroup A: AutisticExperimental treatment 1 intervention
Group B: NeurotypicalExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Oxford Virtual Autism Assessment Tool (OVAAT)
The OVAAT is an online ASD diagnostic tool that has been designed to identify both the external/observable features of autism but also the internal/experiential features of autism.
Time frame
Up to 3 weeks after recruitmentSecondary outcomes
1
Revised Children's Anxiety and Depression Scale (and Subscales) (RCADS)
Used in the screening for group 2 47 item questionnaire scored on a scale of 0-3, with 0 being "never" and 3 being "always"). Participants in group 2 will score statements based on how often the things (statements) happen to them e.g., "I worry about things".
Time frame
Day 02
Autism Spectrum Quotient (AQ-10)
Used in group 2 screening process. 10 item measure that looks at whether a person should be be referred for further autism assessment. Participants are asked to indicate their level of agreement on 10 statements (on a scale of 1-4, 1 being "definitely agree" to 4 "definitely disagree").
Time frame
Day 03
Adult ADHD Self-Report Scale (ASRS)
Used in the group 2 screening process 18-item questionnaire spilt into 2 parts (part a. and part b.). Participants are asked to score rate themselves based on how they have felt and conducted themselves over the past six months (using "never", "rarely", "sometimes", "often" or "very often").
Time frame
Day 04
Prodromal Questionnaire (PQ-16)
Used in group 2 screening process. 16-item questionnaire that asks participants to either indicate "true" or "false" for 16 items that look at the risk of potential psychosis. For any statements that participants indicate as "true" they are asked to rate their level of distress (on a scale of 0-3, with 0 being "none" and 3 being "severe").
Time frame
Day 0Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov